Prescription drug · NDA
Syfovre (Pegcetacoplan) NDC 73606-020
Pegcetacoplan 15 mg/.1mL · Injection, Solution · Intravitreal · Apellis Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73606-020-01 | 73606002001 | 1 VIAL, GLASS in 1 CARTON (73606-020-01) / 3 mL in 1 VIAL, GLASSMarketed from Feb 17, 2023 | |
| 73606-020-02 | 73606002002 | 1 VIAL, GLASS in 1 CARTON (73606-020-02) / 3 mL in 1 VIAL, GLASSMarketed from Nov 7, 2025 | |
| 73606-020-11 | 73606002011 | 1 VIAL, GLASS in 1 CARTON (73606-020-11) / 3 mL in 1 VIAL, GLASSMarketed from Feb 17, 2023 · Sample package | |
| 73606-020-12 | 73606002012 | 1 VIAL, GLASS in 1 CARTON (73606-020-12) / 3 mL in 1 VIAL, GLASSMarketed from Nov 7, 2025 · Sample package |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Syfovre
- Generic name (nonproprietary)
- pegcetacoplan
- Active ingredients
- Pegcetacoplan — 15 mg/.1mL
- Dosage form
- Injection, Solution
- Route
- Intravitreal
- Labeler
- Apellis Pharmaceuticals, Inc.NDC labeler code 73606
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 217171
- Marketing start
- Listing expires
- Other FDA classes
- Complement Inhibitors (Mechanism)
- Identifiers
- Product ID 73606-020_76e1d7d9-903f-49c1-be3a-617f682e79e7SPL ID 76e1d7d9-903f-49c1-be3a-617f682e79e7SPL set ID b4434e61-9ec9-4e0e-bd60-45aaa0a87e64RxCUI 2630847, 2630853UNII TO3JYR3BOU
- Pharmacologic class
- Complement Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N473606002001followed by a unit qualifier and the quantityPackage 73606-0020-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
SYFOVRE is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). SYFOVRE is a complement inhibitor indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 73606-020
- What is NDC 73606-020?
- 73606-020 is the product NDC for Syfovre (pegcetacoplan), Pegcetacoplan 15 mg/.1mL injection, solution, listed with the FDA by Apellis Pharmaceuticals, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Syfovre (Pegcetacoplan).
- What is the active ingredient?
- Pegcetacoplan.
- Who is the labeler?
- Apellis Pharmaceuticals, Inc., NDC labeler code 73606. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Syfovre?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.